✦ LIBER ✦

The angiotensin II receptor antagonist valsartan enhances lipoprotein lipase mass in preheparin serum in type 2 diabetes with hypertension

✍ Scribed by Atsuhito Saiki; Masahiro Ohira; Kei Endo; Nobukiyo Koide; Tomokazu Oyama; Takeyoshi Murano; Yoh Miyashita; Kohji Shirai

Book ID: 116405615
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 182 KB
Volume: 74
Category: Article
ISSN: 0168-8227
DOI: 10.1016/j.diabres.2006.04.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low lipoprotein lipase mass in prehepari

Low lipoprotein lipase mass in preheparin serum of type 2 diabetes mellitus patients and its recovery with insulin therapy

✍ Yoh Miyashita; Kohji Shirai; Yoshiaki Itoh; Hidehisa Sasaki; Mitsuya Totsuka; Ta 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Effects of Olmesartan Medoxomil an Angio

Effects of Olmesartan Medoxomil an Angiotensin II Type 1 Receptor Antagonist, on Plasma Concentration of B-Type Natriuretic Peptide, in Hypertensive Patients with Type 2 Diabetes Mellitus

✍ Dr Toshihide Kawai, Izumi Takei, Akira Shimada, Takumi Hirata, Kumiko Tanaka, Yo 📂 Article 📅 2011 🏛 Springer International Publishing AG 🌐 English ⚖ 142 KB

Comparative effect of angiotensin II typ

Comparative effect of angiotensin II type I receptor blockers on serum uric acid in hypertensive patients with type 2 diabetes mellitus: a retrospective observational study

✍ Nishida, Yayoi; Takahashi, Yasuo; Susa, Norio; Kanou, Nobukazu; Nakayama, Tomohi 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 179 KB

Comparison of the effects of three angio

Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus

✍ Nobuaki Ozaki; Yoshio Nomura; Hiroshi Sobajima; Kunikazu Kondo; Yutaka Oiso 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Short-term oral treatment with the angio

Short-term oral treatment with the angiotensin II receptor antagonist losartan does not improve coronary vasomotor function in asymptomatic type 2 diabetes patients

✍ Andreas Kjær; Ulrik Sloth Kristoffersen; Lise Tarnow; Hans-Henrik Parving; Birge 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 263 KB

The angiotensin II receptor blocker telm

The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control

✍ Akiko Yamana; Mikio Arita; Machi Furuta; Yoshinori Shimajiri; Tokio Sanke 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 239 KB